University of Illinois at Chicago
Announcement of an Exempt Purchase
Cardinal Health Specialty DistributionDublin, OH
- Amount: An estimated $1,200,000
- Terms: An estimated start date of 12/1/2022 through 11/30/2027
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Wednesday, December 7, 2022
The University awarded a contract for chemotherapy drug Asparlas.
Asparlas, a chemotherapy drug used in the treatment of Acute Lymphoblastic Leukemia.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Asparlas is used to treat Acute Lymphoblastic Leukemia patients at UI Health.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.
